|1.||Rajalingam, Kasinathan: 1 article (01/2012)|
|2.||Vijayaanand, Mariadoss Arokia: 1 article (01/2012)|
|3.||Suresh, Kathiresan: 1 article (01/2012)|
|4.||Sugunadevi, Govindasamy: 1 article (01/2012)|
|5.||Sathiyapriya, Jagadeesan: 1 article (01/2012)|
|2.||Chromosome Aberrations (Chromosome Abnormalities)
01/01/2012 - "Oral pretreatment of Mosinone-A (2 mg/kg b.wt) for 5 days to DMBA treated animals significantly reduced the frequency of MnPCEs, chromosomal abnormalities such as chromosomal break, gap, minute, fragment, DNA damage and reversed the status of biochemical variables. "
01/01/2012 - "The frequency of micronucleated polychromatic erythrocytes [MnPCEs], chromosomal aberrations [CA], DNA damage (comet assay) as cytogenetic markers and the status of lipid peroxidation byproducts, antioxidants and phase II detoxification agents were used as biochemical markers to assess the antigenotoxic effect of Mosinone-A on DMBA induced genotoxicity. "
|2.||Biological Markers (Surrogate Marker)